Clin Lab. 2024 Jun 1;70(6). doi: 10.7754/Clin.Lab.2024.240139.
For women, cervical cancer is the most prevalent cancer and the most common cause of cancer-related deaths worldwide. Human papillomavirus (HPV) is causatively linked to over 90% of cervical cancer cases. Our retrospective study explored the clinical and laboratory data of outpatients with HPV infection to analyze the prevalence and genotype distribution of 3,793 outpatients in the Hangzhou area by using HPV genotype tests. It could provide value for an effective prevention and treatment of HPV infection.
In total, 3,793 female outpatients were randomly selected from January 2022 to December 2023. Exfoliated cervical cells were collected using a cytobrush and HPV genotype screening was conducted for testing. Data of all outpatients were collected from the hospital's electronic medical records, and SPSS 26.0 software was used to perform the statistical analysis.
Out of 3,793 outpatients, 953 were detected as positive, and the positive rate was 25.13%. The age of the outpatients ranged from 15 - 97, with an average age of 39.91. All outpatients were divided into six age groups. Among the six age groups, the HPV positive rates were, with ascending age, 43.90%, 33.27%, 21.49%, 16.99%, 27.30%, and 25.48%, and the highest positive rate was observed in those aged 20 with a rate of 43.90%. There were significant differences in the positive rates among different age groups (p < 0.05). There were more outpatients with a single infection than with multiple infection (p < 0.05). The positive rate of single infection was the highest in the 31 - 40 and 41 - 50 age groups (74.32% for both) and the positive rate of multiple infection was the highest in the 20 age group (66.67%). Among 24 genotypes, HPV 52, 58, and 51 were the most commonly detected. All three were high-risk genotypes, and HPV 52 was the most dominant in all age groups. As distribution according to quarter, more HPV infection occurred in the fourth quarter, which had a significant difference (p < 0.05). And in the first quarter, the number of HPV positive infections was the lowest.
Prevalence and genotype distribution of HPV in the Hangzhou area were different from those of other regions. More single infection, and more multiple infection occurring in low age and in the fourth quarter were the characteristics of HPV infection in the Hangzhou area. It was suggested that vaccine containing HPV 52 might be a better choice for this region.
对于女性来说,宫颈癌是最常见的癌症,也是全球癌症相关死亡的最常见原因。人乳头瘤病毒(HPV)与超过 90%的宫颈癌病例有因果关系。我们的回顾性研究通过 HPV 基因型检测,分析了杭州地区 3793 名 HPV 感染门诊患者的临床和实验室数据,以探讨 HPV 感染的流行率和基因型分布。这可为 HPV 感染的有效预防和治疗提供价值。
我们从 2022 年 1 月至 2023 年 12 月随机选择了 3793 名女性门诊患者。使用细胞刷收集宫颈脱落细胞,并进行 HPV 基因型筛查检测。所有患者的数据均从医院的电子病历中收集,并使用 SPSS 26.0 软件进行统计分析。
在 3793 名门诊患者中,有 953 名检测为阳性,阳性率为 25.13%。患者年龄为 15-97 岁,平均年龄为 39.91 岁。所有患者分为六个年龄组。在这六个年龄组中,HPV 阳性率分别为 43.90%、33.27%、21.49%、16.99%、27.30%和 25.48%,最高阳性率出现在20 岁年龄组,为 43.90%。不同年龄组的阳性率有显著差异(p<0.05)。单一感染的患者多于多重感染的患者(p<0.05)。单一感染的阳性率在 31-40 岁和 41-50 岁年龄组最高(均为 74.32%),多重感染的阳性率在20 岁年龄组最高(66.67%)。在 24 种基因型中,HPV 52、58 和 51 是最常检测到的三种高危型。所有三种基因型均为高危型,且 HPV 52 在所有年龄组中最为优势。按照季度分布,第四季度 HPV 感染较多,差异有统计学意义(p<0.05)。而在第一季度,HPV 阳性感染的数量最低。
杭州地区 HPV 的流行率和基因型分布与其他地区不同。该地区 HPV 感染的特征为更多的单一感染、更多的低龄和第四季度多重感染。建议该地区选择包含 HPV 52 的疫苗可能是更好的选择。